Clinical research and collaborations
Assessing a system intended for clinical practice
Explore the pathwayProject in development · Pathways defined by the professionalAssessing a system intended for clinical practice
The development of LUCIDA VR requires collaboration between clinical expertise, activity design and technical verification. The contribution of neurologists, geriatricians, neuropsychologists and rehabilitation professionals is essential to define relevant goals and methods of use consistent with the intended population.
Universities, clinical centres and care facilities can contribute to assessing how understandable, tolerable and sustainable the pathway is. Involving individuals and caregivers helps identify difficulties that do not emerge from technical observation of the system alone.
From feasibility to clinical outcomes
The first assessment phase concerns whether the system can be used as intended: headset acceptance, understanding of instructions, interaction accuracy, assistance required and interruptions. These data indicate whether the pathway is feasible, but do not on their own demonstrate therapeutic efficacy.
Outcome assessment requires independent cognitive measures, functional indicators and an appropriate comparator. Sample characteristics, concomitant treatments and the duration of observation influence interpretation of the results.
Documenting assistance and performance conditions
To distinguish independent from assisted performance, the project envisages recording assistance provided and interruptions. Visual, hearing or motor difficulties and technical problems must also be considered when interpreting sessions.
The use of AI-generated summaries requires verifiability. The original data and the professional's interpretation must remain identifiable; any automated alerts do not constitute diagnoses.
Sharing results
Formalised collaborations and specific studies will be presented with details of the centre, protocol, system version and project status. Preliminary results, protocols and final publications will be identified separately.
The aim is to build clear, verifiable clinical documentation that helps establish for whom and under what conditions LUCIDA VR may have a role in care.
Propose a scientific collaboration
In the same area
